The Effect of Reproductive Factors on Coronary Artery Disease in Women
Advances in Nursing & Midwifery,
Vol. 28 No. 2 (2019),
2 April 2019
,
Page 9-13
Abstract
Abstract Introduction: There is a sex discrepancy in cardiovascular physiology. In this study, we aimed to investigate the effect of female reproductive factors on coronary artery disease (CAD) beyond the known CAD risk factors. Methods: In a case-control study, women referred to Tehran Heart Center for coronary artery angiography from 2012 to 2014 were enrolled. Of these, 80 premenopausal and 100 postmenopausal females with CAD in angiography were randomly selected as cases and 80 premenopausal and 100 postmenopausal females without CAD in angiography were selected as controls. A questionnaire including reproductive history and known CAD risk factors was filled for every subject. Analysis was performed separately for pre and postmenopausal women and a final adjustment for coronary artery disease risk factors was done. Results: Among reproductive factors, oligomenorrhea (OR= 6.72) was a significant risk factor for CAD in premenopausal women and history of oral contraceptive (OCP) use had a protective effect on CAD in pre and postmenopausal woman (OR= 0.24 and 0.20, respectively). Conclusions: Since oligomenorrhea has a strong association with insulin resistance and diabetes, a conventional risk factor of CAD, women with oligomenorrhea should be treated not only for cyclic irregularity but also for prevention of CAD.- Coronary Artery Disease Contraceptives
- Oral Oligomenorrhea
How to Cite
References
Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science. 2005;308(5728):1583-7. doi: 10.1126/science.1112062 pmid: 15947175
Ness RB, Harris T, Cobb J, Flegal KM, Kelsey JL, Balanger A, et al. Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med. 1993;328(21):1528-33. doi: 10.1056/NEJM199305273282104 pmid: 8267704
Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ. 2002;325(7356):157-60. pmid: 12130616
Solomon CG, Hu FB, Dunaif A, Rich-Edwards JE, Stampfer MJ, Willett WC, et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab. 2002;87(5):2013-7. doi: 10.1210/jcem.87.5.8471 pmid: 11994334
Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol. 1995;15(7):821-6. pmid: 7600112
World Medical Association. Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2001;8(3):221-4.
Noel Bairey Merz C, Johnson BD, Sharaf BL, Bittner V, Berga SL, Braunstein GD, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol. 2003;41(3):413-9. doi: 10.1016/s0735-1097(02)02763-8
Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. A prospective study of age at menarche, parity, age at first birth, and coronary heart disease in women. Am J Epidemiol. 1987;126(5):861-70. pmid: 3661534
Kharazmi E, Fallah M, Luoto R. Maternal Age at First Delivery and Risk of Cardiovascular Disease Later in Life. ISRN Epidemiol. 2013:724-30.
Cooper GS, Ephross SA, Weinberg CR, Baird DD, Whelan EA, Sandler DP. Menstrual and reproductive risk factors for ischemic heart disease. Epidemiology. 1999;10(3):255-9. doi: 10.1097/00001648-199905000-00011 pmid: 10230834
Hardy R, Lawlor DA, Black S, Mishra GD, Kuh D. Age at birth of first child and coronary heart disease risk factors at age 53 years in men and women: British birth cohort study. J Epidemiol Community Health. 2009;63(2):99-105. doi: 10.1136/jech.2008.076943 pmid: 18782806
Pirkle CM, de Albuquerque Sousa AC, Alvarado B, Zunzunegui MV, Group IR. Early maternal age at first birth is associated with chronic diseases and poor physical performance in older age: cross-sectional analysis from the International Mobility in Aging Study. BMC Public Health. 2014;14:293. doi: 10.1186/1471-2458-14-293 pmid: 24684705
Hardy R, Lawlor DA, Black S, Wadsworth ME, Kuh D. Number of children and coronary heart disease risk factors in men and women from a British birth cohort. BJOG. 2007;114(6):721-30. doi: 10.1111/j.1471-0528.2007.01324.x pmid: 17516964
Parikh NI, Cnattingius S, Dickman PW, Mittleman MA, Ludvigsson JF, Ingelsson E. Parity and risk of later-life maternal cardiovascular disease. Am Heart J. 2010;159(2):215-21 e6. doi: 10.1016/j.ahj.2009.11.017 pmid: 20152219
Jacobsen BK, Knutsen SF, Oda K, Fraser GE. Parity and total, ischemic heart disease and stroke mortality. The Adventist Health Study, 1976-1988. Eur J Epidemiol. 2011;26(9):711-8. doi: 10.1007/s10654-011-9598-x pmid: 21701914
Wang ET, Cirillo PM, Vittinghoff E, Bibbins-Domingo K, Cohn BA, Cedars MI. Menstrual irregularity and cardiovascular mortality. J Clin Endocrinol Metab. 2011;96(1):E114-8. doi: 10.1210/jc.2010-1709 pmid: 20980429
He L, Tang X, Li N, Wu YQ, Wang JW, Li JR, et al. Menopause with cardiovascular disease and its risk factors among rural Chinese women in Beijing: a population-based study. Maturitas. 2012;72(2):132-8. doi: 10.1016/j.maturitas.2012.02.013 pmid: 22445219
Mueller NT, Odegaard AO, Gross MD, Koh WP, Yuan JM, Pereira MA. Age at menarche and cardiovascular disease mortality in Singaporean Chinese women: the Singapore Chinese Health Study. Ann Epidemiol. 2012;22(10):717-22. doi: 10.1016/j.annepidem.2012.08.002 pmid: 22939833
Wu X, Cai H, Kallianpur A, Gao YT, Yang G, Chow WH, et al. Age at menarche and natural menopause and number of reproductive years in association with mortality: results from a median follow-up of 11.2 years among 31,955 naturally menopausal Chinese women. PLoS One. 2014;9(8):e103673. doi: 10.1371/journal.pone.0103673 pmid: 25090234
Canoy D, Beral V, Balkwill A, Wright FL, Kroll ME, Reeves GK, et al. Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort. Circulation. 2015;131(3):237-44. doi: 10.1161/CIRCULATIONAHA.114.010070 pmid: 25512444
Qiu C, Chen H, Wen J, Zhu P, Lin F, Huang B, et al. Associations between age at menarche and menopause with cardiovascular disease, diabetes, and osteoporosis in Chinese women. J Clin Endocrinol Metab. 2013;98(4):1612-21. doi: 10.1210/jc.2012-2919 pmid: 23471979
Kaplan JR, Adams MR, Anthony MS, Morgan TM, Manuck SB, Clarkson TB. Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. Arterioscler Thromb Vasc Biol. 1995;15(12):2094-100. pmid: 7489229
Merz CN, Johnson BD, Berga S, Braunstein G, Reis SE, Bittner V, et al. Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Fertil Steril. 2006;85(5):1425-31. doi: 10.1016/j.fertnstert.2006.01.009 pmid: 16600235
Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. Past use of oral contraceptives and cardiovascular disease: A meta-analysis in the context of the Nurses’ Health Study. Am J Obstet Gynecol. 1990;163(1):285-91. doi: 10.1016/0002-9378(90)90569-s
Friedman J, Cremer M, Jelani QU, Huang X, Jian J, Shah S, et al. Oral contraceptive use, iron stores and vascular endothelial function in healthy women. Contraception. 2011;84(3):285-90. doi: 10.1016/j.contraception.2011.01.012 pmid: 21843695
- Abstract Viewed: 153 times
- PDF Downloaded: 209 times